norfenfluramine has been researched along with Obesity in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (75.00) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miller, KJ | 1 |
| Chalmers, SR; Douglas, JG; Frazer, I; Gough, J; Haslett, C; Munro, JF; Preston, PG | 1 |
| Bareggi, SR; Boni, S; Bonini, LM; Magnoni, V; Zecca, L | 1 |
| Wales, JK | 1 |
| Rowland, NE | 1 |
| Bizzi, A; Garattini, S; Morselli, PL; Tacconi, MT; Tognoni, G | 1 |
| Campbell, DB; Ford, MJ; Innes, JA; Munro, JF; Stoddart, ME; Watson, ML | 1 |
| Macrae, SM | 1 |
| Campbell, DB; Hossain, M | 1 |
| Carlton, J; Rowland, NE | 1 |
| Caccia, S; Fracasso, C; Garattini, S; Guiso, G | 1 |
| Beeley, NR; Bjenning, C; Chen, RR; Covel, JA; Dosa, PI; Espitia, S; Estrada, SA; Gallardo, CS; Gilson, CA; Grottick, AJ; Martin, M; Menzaghi, F; Morgan, M; Park, DM; Prieto, EB; Ren, A; Saldana, HR; Schultz, JA; Sengupta, D; Smith, BM; Smith, JM; Thomsen, WJ; Tsai, JH; Webb, RR; Whelan, KT | 1 |
3 review(s) available for norfenfluramine and Obesity
| Article | Year |
|---|---|
Serotonin 5-ht2c receptor agonists: potential for the treatment of obesity.
Topics: Animals; Fenfluramine; Humans; Norfenfluramine; Obesity; Receptor, Serotonin, 5-HT2C; Serotonin Receptor Agonists; Treatment Outcome | 2005 |
Peripheral and metabolic effects of fenfluramine, 780SE, norfenfluramine and hydroxyethylnorfenfluramine--a review.
Topics: Adipose Tissue; Amphetamines; Animals; Autonomic Nervous System; Blood Pressure; Cats; Dogs; Fenfluramine; Glucose; Guinea Pigs; Humans; Lipid Metabolism; Muscles; Norfenfluramine; Obesity; Rabbits; Rats; Structure-Activity Relationship; Triglycerides | 1975 |
Tolerance to fenfluramine anorexia: fact or fiction?
Topics: Animals; Behavior Therapy; Body Weight; Brain; Brain Chemistry; Drug Tolerance; Feeding Behavior; Female; Fenfluramine; Gastric Emptying; Hydroxyindoleacetic Acid; Intestines; Male; Norfenfluramine; Obesity; Rats; Rats, Inbred Strains; Self Stimulation; Serotonin; Stomach | 1986 |
3 trial(s) available for norfenfluramine and Obesity
| Article | Year |
|---|---|
Long-term efficacy of fenfluramine in treatment of obesity.
Topics: Body Weight; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Method; Female; Fenfluramine; Humans; Hypertension, Pulmonary; Norfenfluramine; Obesity; Recurrence; Tablets; Time Factors | 1983 |
Plasma fenfluramine levels, weight loss, and side effects.
Topics: Adult; Aged; Body Weight; Female; Fenfluramine; Humans; Middle Aged; Norfenfluramine; Obesity | 1977 |
Fenfluramine and methylcellulose in the treatment of obesity: the relationship between plasma drug concentrations and therapeutic efficacy.
Topics: Adolescent; Adult; Aged; Biological Availability; Clinical Trials as Topic; Diet, Reducing; Female; Fenfluramine; Humans; Male; Methylcellulose; Middle Aged; Norfenfluramine; Obesity | 1975 |
6 other study(ies) available for norfenfluramine and Obesity
| Article | Year |
|---|---|
[Activity of fenfluramine in obese subjects. Relation between dosage, plasma concentration of the drug and its effect on weight loss].
Topics: Adult; Aged; Body Weight; Dose-Response Relationship, Drug; Female; Fenfluramine; Humans; Male; Middle Aged; Norfenfluramine; Obesity | 1982 |
The effect of fenfluramine on weight loss during restricted dietary regimes.
Topics: Body Weight; Female; Fenfluramine; Humans; Male; Norfenfluramine; Obesity | 1980 |
Long-term administration of dexfenfluramine to genetically obese (ob/ob) and lean mice: body weight and brain serotonin changes.
Topics: Animals; Blood Glucose; Body Weight; Brain Chemistry; Corticosterone; Dietary Fats; Female; Fenfluramine; Mice; Mice, Inbred C57BL; Mice, Obese; Norfenfluramine; Obesity; Paroxetine; Serotonin | 1994 |
Distribution of fenfluramine in normal and obese mice.
Topics: Adipose Tissue; Animals; Aurothioglucose; Brain; Female; Fenfluramine; Mice; Norfenfluramine; Obesity | 1978 |
Disposition of D-fenfluramine in lean and obese rats.
Topics: Animals; Cytochrome P-450 Enzyme System; Female; Fenfluramine; Half-Life; Kinetics; Microsomes, Liver; Norfenfluramine; Obesity; Proteins; Rats; Rats, Inbred Strains; Rats, Mutant Strains; Rats, Zucker | 1988 |
Discovery and structure-activity relationship of (1R)-8-chloro-2,3,4,5-tetrahydro-1-methyl-1H-3-benzazepine (Lorcaserin), a selective serotonin 5-HT2C receptor agonist for the treatment of obesity.
Topics: Animals; Anti-Obesity Agents; Benzazepines; Cell Line; Eating; Humans; Inositol 1,4,5-Trisphosphate; Male; Obesity; Rats; Rats, Sprague-Dawley; Serotonin 5-HT2 Receptor Agonists; Stereoisomerism; Structure-Activity Relationship; Weight Gain | 2008 |